Phase 2 Safety and Immunogenicity Study of Rift Valley Fever Vaccine
NCT03609398
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
This study is to collect safety and immunogenicity data for an Rift Valley Fever (RVF) vaccine
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Rift Valley Fever
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 2
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- U.S. Army Medical Research and Development Command
- Last updated on ClinicalTrials.gov
- February 11, 2021
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Maryland · 1
- Special Immunization Program, Division of Medicine, USAMRIID · Fort Deterick, MD
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.